Revvity Future Growth
Future criteria checks 2/6
Revvity is forecast to grow earnings and revenue by 19.9% and 5.9% per annum respectively. EPS is expected to grow by 18.9% per annum. Return on equity is forecast to be 7.7% in 3 years.
Key information
19.9%
Earnings growth rate
18.9%
EPS growth rate
Life Sciences earnings growth | 26.1% |
Revenue growth rate | 5.9% |
Future return on equity | 7.7% |
Analyst coverage | Good |
Last updated | 26 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 3,118 | 392 | 759 | 849 | 11 |
12/31/2025 | 2,908 | 333 | 678 | 764 | 15 |
12/31/2024 | 2,757 | 270 | 565 | 653 | 13 |
9/29/2024 | 2,722 | 258 | 564 | 651 | N/A |
6/30/2024 | 2,708 | 197 | 383 | 469 | N/A |
3/31/2024 | 2,726 | 183 | 97 | 175 | N/A |
12/31/2023 | 2,751 | 180 | 10 | 91 | N/A |
10/1/2023 | 2,796 | 213 | -50 | 34 | N/A |
7/2/2023 | 2,837 | 250 | 153 | 227 | N/A |
4/2/2023 | 3,024 | 353 | 380 | 460 | N/A |
1/1/2023 | 3,312 | 513 | 594 | 680 | N/A |
10/2/2022 | 3,599 | 599 | 790 | 876 | N/A |
7/3/2022 | 3,748 | 637 | 932 | 1,030 | N/A |
4/3/2022 | 3,483 | 694 | 1,122 | 1,220 | N/A |
1/2/2022 | 3,828 | 889 | 1,325 | 1,411 | N/A |
10/3/2021 | 4,155 | 1,086 | 1,478 | 1,557 | N/A |
7/4/2021 | 4,257 | 1,155 | 1,380 | 1,455 | N/A |
4/4/2021 | 4,438 | 1,074 | 1,234 | 1,306 | N/A |
1/3/2021 | 2,663 | 631 | 829 | 892 | N/A |
10/4/2020 | 3,234 | 412 | 545 | 625 | N/A |
7/5/2020 | 2,977 | 294 | 444 | 521 | N/A |
4/5/2020 | 2,887 | 226 | 352 | 429 | N/A |
12/29/2019 | 2,884 | 228 | 282 | 363 | N/A |
9/29/2019 | 2,835 | 235 | 217 | 308 | N/A |
6/30/2019 | 2,802 | 251 | 199 | 294 | N/A |
3/31/2019 | 2,783 | 247 | 225 | 320 | N/A |
12/30/2018 | 2,778 | 237 | 218 | 311 | N/A |
9/30/2018 | 2,663 | 128 | 203 | 280 | N/A |
7/1/2018 | 2,543 | 149 | N/A | 245 | N/A |
4/1/2018 | 2,387 | 147 | N/A | 220 | N/A |
12/31/2017 | 2,257 | 157 | N/A | 288 | N/A |
10/1/2017 | 2,182 | 258 | N/A | 309 | N/A |
7/2/2017 | 2,142 | 215 | N/A | 324 | N/A |
4/2/2017 | 2,132 | 210 | N/A | 372 | N/A |
1/1/2017 | 2,116 | 216 | N/A | 351 | N/A |
10/2/2016 | 1,999 | 198 | N/A | 327 | N/A |
7/3/2016 | 2,048 | 199 | N/A | 314 | N/A |
4/3/2016 | 2,076 | 190 | N/A | 281 | N/A |
1/3/2016 | 2,105 | 189 | N/A | 287 | N/A |
10/4/2015 | 2,263 | 176 | N/A | 258 | N/A |
6/28/2015 | 2,241 | 164 | N/A | 261 | N/A |
3/29/2015 | 2,234 | 167 | N/A | 252 | N/A |
12/28/2014 | 2,070 | 130 | N/A | 282 | N/A |
9/28/2014 | 2,221 | 203 | N/A | 257 | N/A |
6/29/2014 | 2,201 | 201 | N/A | 242 | N/A |
3/30/2014 | 2,185 | 176 | N/A | 215 | N/A |
12/29/2013 | 2,158 | 174 | N/A | 159 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PKN's forecast earnings growth (19.9% per year) is above the savings rate (1%).
Earnings vs Market: PKN's earnings (19.9% per year) are forecast to grow slower than the German market (20.9% per year).
High Growth Earnings: PKN's earnings are forecast to grow, but not significantly.
Revenue vs Market: PKN's revenue (5.9% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: PKN's revenue (5.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PKN's Return on Equity is forecast to be low in 3 years time (7.7%).